NPC Strengthens Its Evidence-based Medicine Research Team
Washington, DC. (July 6, 2009) – The National Pharmaceutical Council (NPC) today announced that Jennifer Graff, PharmD, has joined the organization as Research Director, Methods, Evidence and Coverage. In this new position, Dr. Graff will be working with NPC Vice President for Clinical and Scientific Affairs Les Paul, MD, MS, to advance the numerous evidence-based medicine (EBM) and innovation research initiatives NPC has underway.
“Jennifer is joining us at a critical time as we move forward with new projects focusing on EBM and comparative effectiveness research,” said Dr. Paul. “Her extensive research and pharmacoeconomics background make her especially well suited to the development of our growing portfolio of research.”
Most recently, Dr. Graff served as Associate Director of Health Outcomes and Pharmacoeconomics at MedImmume, where she was responsible for health outcomes and pharmacoeconomics for 10 products in clinical development for the respiratory and inflammation therapy areas. She also developed strategic research and case studies to identify market challenges and enhance product differentiation. Prior to MedImmune, she held several positions at the Pfizer Pharmaceuticals Group, most recently as the Associate Director for Worldwide Outcomes Research. Dr. Graff holds a Doctorate of Pharmacy from the University of Nebraska Medical Center, and completed a Health Outcomes and Pharmacoeconomics fellowship at the University of Michigan.
“Since 2007, we have continued to expand NPC’s contributions to the rigorous research and stakeholder dialogue on comparative effectiveness and evidence-based medicine,” said NPC President Dan Leonard. “We’re pleased that Jennifer has joined NPC to help us with those efforts.”
About the National Pharmaceutical Council
NPC’s overarching mission is to sponsor and conduct scientific analyses of the appropriate use of biopharmaceuticals and the clinical and economic value of innovation. The organization’s strategic focus is on evidence-based medicine (EBM) for health care decision-making, to ensure that patients have access to high-quality care. NPC was established in 1953 and is supported by the nation’s major research-based pharmaceutical companies. For more information, visit www.npcnow.org.
# # #